 Connection
Marsha Anderson to Immunoglobulins, Intravenous
This is a "connection" page, showing publications Marsha Anderson has written about Immunoglobulins, Intravenous.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.615 |
|
|
|
-
Dominguez SR, Birkholz M, Anderson MS, Heizer H, Jone PN, Glode MP, Todd JK. Diagnostic and Treatment Trends in Children With Kawasaki Disease in the United States, 2006-2015. Pediatr Infect Dis J. 2019 10; 38(10):1010-1014.
Score: 0.157
-
Jone PN, Anderson MS, Mulvahill MJ, Heizer H, Glod? MP, Dominguez SR. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective? Pediatr Infect Dis J. 2018 10; 37(10):976-980.
Score: 0.146
-
Dominguez SR, Martin B, Heizer H, Jone PN, Tong S, Davidson J, Anderson MS, Glod? MP. Procalcitonin (PCT) and Kawasaki Disease: Does PCT Correlate With IVIG-Resistant Disease, Admission to the Intensive Care Unit, or Development of Coronary Artery Lesions? J Pediatric Infect Dis Soc. 2016 Sep; 5(3):297-302.
Score: 0.115
-
Dominguez SR, Anderson MS. Advances in the treatment of Kawasaki disease. Curr Opin Pediatr. 2013 Feb; 25(1):103-9.
Score: 0.099
-
Anderson MS, Todd JK, Glod? MP. Delayed diagnosis of Kawasaki syndrome: an analysis of the problem. Pediatrics. 2005 Apr; 115(4):e428-33.
Score: 0.057
-
Jone PN, Korst A, Karimpour-Fard A, Thomas T, Dominguez SR, Heizer H, Anderson MS, Glode MP, Sucharov CC, Miyamoto SD. Circulating microRNAs differentiate Kawasaki Disease from infectious febrile illnesses in childhood. J Mol Cell Cardiol. 2020 09; 146:12-18.
Score: 0.041
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|